8A82 - Trigeminal Autonomic Cephalalgias: Complete Clinical Coding Guide

1. Introduction

Trigeminal autonomic cephalalgias represent a distinct group of primary headache disorders characterized by a unique combination of unilateral headache pain and prominent autonomic symptoms. This group of conditions, although less prevalent than migraines and tension-type headaches, presents striking clinical features that include intense pain, frequently described as lancinating or burning, accompanied by ipsilateral autonomic manifestations such as lacrimation, nasal congestion, ptosis, and facial diaphoresis.

The clinical importance of this group of disorders lies not only in the intensity of suffering they cause to patients, but also in the significant impact on quality of life and functional capacity. Patients with trigeminal autonomic cephalalgias frequently experience recurrent and disabling attacks, which may occur multiple times per day in some cases, resulting in substantial impairment of daily, professional, and social activities.

The exact prevalence varies according to the specific subtype within this group, but collectively these conditions affect millions of people worldwide. Proper recognition and accurate coding are fundamental to ensure appropriate treatment, effective epidemiological monitoring, and adequate allocation of health resources.

Correct coding using ICD-11 is critical for multiple reasons: it enables precise epidemiological tracking, facilitates clinical research, ensures appropriate reimbursement of medical procedures, and guarantees that patients receive evidence-based treatments specific to their condition. The distinction between trigeminal autonomic cephalalgias and other types of primary headaches is essential to avoid inappropriate treatments and ensure better clinical outcomes.

2. Correct ICD-11 Code

Code: 8A82

Description: Trigeminal autonomic cephalalgias

Parent category: Headache disorders

Official definition: Group of primary headache disorders essentially characterized by unilateral headache and trigeminal autonomic activation. In most of these disorders, but not all, the headache is of short duration and highly recurrent, but sometimes remits for long periods.

This code represents a comprehensive category that encompasses various subtypes of headaches with shared pathophysiological characteristics. The ICD-11 classification recognizes the importance of grouping these conditions due to their common neurobiological mechanisms, which involve activation of the trigeminovascular system and the trigeminal autonomic reflex.

The structure of code 8A82 reflects the hierarchical organization of ICD-11, positioning itself within the chapter of headache disorders and clearly differentiating itself from other categories of primary headaches. Adequate coding requires understanding not only the clinical characteristics, but also the temporal context and pattern of symptom recurrence.

It is fundamental that healthcare professionals understand that this code should be used when autonomic features are prominent and constitute an integral part of the clinical presentation, not merely occasional or secondary symptoms. The presence of ipsilateral autonomic symptoms to the pain is an essential diagnostic criterion that distinguishes this group from other primary headaches.

3. When to Use This Code

Code 8A82 should be applied in specific clinical situations where the defining characteristics of trigeminal autonomic cephalalgias are clearly present:

Scenario 1: Unilateral Pain Attacks with Lacrimation and Nasal Congestion A patient presents with recurrent episodes of intense pain strictly unilateral in location, localized to the orbital, supraorbital, or temporal region, with variable duration. During attacks, abundant lacrimation is observed in the eye ipsilateral to the pain, unilateral nasal congestion, and rhinorrhea. The pain is described as excruciating, leading the patient to agitation. This clinical pattern with prominent and consistent autonomic symptoms justifies the use of code 8A82.

Scenario 2: Recurrent Episodes with Characteristic Temporal Pattern Patient reports multiple headache episodes over weeks or months, followed by periods of complete remission that may last months or years. During active periods, attacks occur with regularity, often at the same time of day. Each attack is accompanied by ptosis and miosis ipsilateral to the pain, in addition to unilateral facial diaphoresis. This pattern of recurrence with remission periods and characteristic autonomic symptoms indicates appropriate application of the code.

Scenario 3: Short-Duration Pain with Intense Autonomic Symptoms A patient experiences multiple daily attacks of extremely intense pain, each lasting from a few minutes to several hours. The pain is strictly unilateral and accompanied by conjunctival injection, eyelid edema, and sensation of ear fullness on the same side as the pain. The high frequency of attacks with prominent autonomic symptoms clearly characterizes a trigeminal autonomic cephalgia.

Scenario 4: Presentation with Restlessness and Agitation During Attacks Unlike other headaches where the patient seeks rest, in this case the patient exhibits restless behavior during attacks, pacing back and forth, unable to remain still. The pain is accompanied by marked conjunctival injection and profuse unilateral lacrimation. This characteristic behavior associated with autonomic symptoms supports the diagnosis of trigeminal autonomic cephalgia.

Scenario 5: Characteristic Response to Specific Treatments Patient with a history of recurrent unilateral headache attacks with autonomic symptoms who demonstrates rapid and specific response to treatments directed at trigeminal autonomic cephalalgias, such as oxygen therapy or specific medications. The characteristic therapeutic response reinforces the diagnosis and justifies appropriate coding.

Scenario 6: Documentation of Objective Autonomic Symptoms During clinical evaluation at the time of an attack, autonomic signs ipsilateral to the pain are objectively observed: measurable ptosis, evident miosis, visible lacrimation, marked conjunctival injection, and asymmetric facial diaphoresis. Objective documentation of these signs during the attack provides robust evidence for coding with 8A82.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 8A82 is not appropriate, avoiding coding errors that may compromise patient care:

Bilateral Headache without Prominent Autonomic Symptoms When the headache is predominantly bilateral or alternates sides between different episodes, without consistent and prominent autonomic symptoms, other codes are more appropriate. The bilaterality of pain suggests migraine (8A80) or tension-type headache (8A81), depending on additional characteristics.

Mild or Inconsistent Autonomic Symptoms If autonomic symptoms are present only occasionally or are mild and do not constitute a prominent feature of the clinical presentation, code 8A82 should not be used. Many types of headache may present with mild occasional autonomic symptoms without characterizing a trigeminal autonomic cephalgia.

Headaches Secondary to Other Conditions When headache with autonomic characteristics is secondary to another identifiable medical condition, such as brain tumor, aneurysm, arterial dissection, or other structural pathologies, the appropriate code should reflect the underlying cause, not the symptom pattern. Adequate investigation is essential to exclude secondary causes before coding as primary headache.

Migraine with Autonomic Symptoms Some patients with migraine may present autonomic symptoms during attacks, but if the overall pattern, duration, and other characteristics are consistent with migraine, code 8A80 is more appropriate. Differentiation is based on typical attack duration, presence of aura, pain characteristics, and prominence of autonomic symptoms.

Atypical Facial Pain or Neuralgias Conditions such as trigeminal neuralgia, which may cause intense unilateral facial pain, require specific codes different from 8A82. The absence of prominent autonomic symptoms and the pain pattern (shock-like in neuralgia) aid in differentiation.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of trigeminal autonomic cephalgia diagnosis requires systematic evaluation of specific criteria. Begin with detailed history focusing on: strict pain location (unilateral), pain quality and intensity, duration of each episode, frequency of attacks, and presence of ipsilateral autonomic symptoms.

During evaluation, specifically document: lacrimation, nasal congestion or rhinorrhea, eyelid edema, facial and frontal sweating, facial flushing, sensation of ear fullness, miosis and/or ptosis. At least one autonomic symptom must be present consistently and prominently.

Utilize standardized assessment instruments such as headache diaries to document frequency, duration, and temporal pattern of attacks. Ask the patient to record associated symptoms during each episode. Prospective documentation is more reliable than retrospective recall.

Physical examination during an attack, when possible, provides valuable objective evidence. Observe and document visible autonomic signs. Complete neurological examination is essential to exclude warning signs suggesting secondary causes.

Step 2: Verify Specifiers

Although code 8A82 is the general category, it is important to document specific characteristics that may influence clinical management. Record the typical duration of individual attacks, which may vary from minutes to hours depending on the specific subtype.

Document attack frequency: multiple times per day, daily, or less frequently. Identify whether there is a predictable temporal pattern, such as attacks occurring at the same time of day or related to circadian cycles.

Characterize the recurrence pattern over time: episodic (with periods of remission) or chronic (without significant periods of remission). This distinction has important therapeutic implications.

Assess severity through functional impact: interference with daily activities, need to interrupt activities during attacks, and overall quality of life. Utilize impact scales when available.

Step 3: Differentiate from Other Codes

8A80 - Migraine: The main difference lies in the typical duration of attacks and prominence of autonomic symptoms. Migraines typically last 4-72 hours, whereas some trigeminal autonomic cephalalgias have shorter attacks. In migraine, autonomic symptoms, when present, are less prominent. Migraine frequently presents with nausea and bilateral photophobia/phonophobia, whereas trigeminal autonomic cephalalgias have prominent ipsilateral autonomic symptoms.

8A81 - Tension-Type Headache: Tension-type headaches are typically bilateral, with pressing or tightening quality, mild to moderate intensity, and absence of significant autonomic symptoms. Pain is not aggravated by routine physical activity. The contrast with the intense unilateral pain and autonomic symptoms of trigeminal autonomic cephalalgias is clear.

8A83 - Other Primary Headache Disorder: This code is used for primary headaches that do not fit into the main categories. If the characteristics of trigeminal autonomic cephalgia are clearly present (unilaterality and prominent autonomic symptoms), 8A82 is always preferable to 8A83.

Step 4: Required Documentation

Checklist of Mandatory Information:

• Precise pain location (specify unilateral region)
• Pain quality (specific patient descriptors)
• Pain intensity (numeric or descriptive scale)
• Duration of each individual attack
• Attack frequency (per day, week, month)
• Autonomic symptoms present (list specifically)
• Laterality of autonomic symptoms (confirm ipsilaterality)
• Temporal pattern (preferred time of day, seasonality)
• Identified triggering factors
• Response to previous treatments
• Functional impact and quality of life
• Neurological examination (confirm absence of focal deficits)
• Investigations performed to exclude secondary causes

How to Record Appropriately:

Use clear and objective language in the medical record. Document objective observations separately from patient subjective reports. Include date and time when symptoms were directly observed. Record quantitative measurements when possible (for example, pupil size, degree of ptosis). Maintain headache diaries as part of the medical record. Document clinical reasoning for the choice of specific code.

6. Complete Practical Example

Clinical Case

A 35-year-old male patient presents to the neurology service with a complaint of recurrent episodes of intense headache for approximately two months. He reports that the pain is always on the right side of the head, located mainly in the orbital and temporal region. He describes the pain as "unbearable," "burning," and "as if someone were piercing my eye."

The episodes occur one to two times per day, predominantly at night, frequently awakening him from sleep between 1 AM and 3 AM. Each attack lasts approximately 45 to 90 minutes. During the attacks, the patient reports that he cannot stay still, walks around the house, and feels the need to press the painful area.

Accompanying the pain, the patient consistently notices abundant tearing in the right eye, ocular redness, drooping eyelid on the same side, and right nasal congestion with clear rhinorrhea. The patient's wife confirms that during the attacks she observes the patient's right eye tearing intensely and the eyelid partially closed.

The patient denies nausea, vomiting, sensitivity to light or sounds during the attacks. He does not identify specific triggering factors, although he notes that alcohol consumption seems to precipitate attacks. He denies a family history of similar headaches. He reports that before these two months of frequent attacks, he had never experienced significant headaches.

Neurological examination during consultation (outside of attack) is normal, without focal deficits. Basic ophthalmological examination normal. Fundoscopy without papilledema. There are no alarm signs suggesting secondary cause, but due to the recent onset, neuroimaging is requested to exclude structural pathology.

Brain magnetic resonance imaging returns without significant abnormalities, excluding secondary causes. Headache diary maintained for two weeks confirms attack pattern: 10 episodes in the period, all with similar characteristics, always unilateral on the right, always accompanied by ipsilateral autonomic symptoms.

Step-by-Step Coding

Criteria Analysis:

1. Unilaterality: Confirmed - pain strictly on the right side
2. Ipsilateral autonomic symptoms: Present and prominent - tearing, conjunctival injection, ptosis, nasal congestion, all on the right
3. Duration of attacks: 45-90 minutes - consistent with trigeminal autonomic cephalgia
4. Frequency: 1-2 attacks per day during active period
5. Quality of pain: Intense, excruciating - typical of the disorder
6. Behavior during attack: Restlessness, agitation - characteristic
7. Secondary causes: Excluded by neuroimaging

Code Selected: 8A82 - Trigeminal Autonomic Cephalalgias

Complete Justification:

This case clearly exemplifies a trigeminal autonomic cephalgia. The presence of strict unilateral pain, consistently accompanied by multiple prominent ipsilateral autonomic symptoms (tearing, conjunctival injection, ptosis, nasal congestion), constitutes the essential diagnostic pattern for this category.

The duration of attacks (45-90 minutes) and frequency (1-2 per day) are characteristic. The behavior of restlessness during attacks, in contrast to the desire for rest typical of migraine, is highly suggestive. The temporal pattern with nocturnal predilection and regular timing is consistent with trigeminal autonomic cephalgia.

The absence of significant nausea, the short duration compared to typical migraine, and the prominence of autonomic symptoms distinguish this case from migraine (8A80). The severe intensity and unilateral nature with autonomic symptoms exclude tension-type headache (8A81).

The exclusion of secondary causes through appropriate neuroimaging confirms that this is a primary headache, justifying the use of code 8A82 instead of codes for secondary headaches.

Complementary Codes:

In this specific case, there are no documented comorbidities requiring additional coding. If the patient develops complications such as anxiety disorder related to fear of attacks, or if there is excessive medication use, appropriate additional codes should be included.

7. Related Codes and Differentiation

Within the Same Category

8A80: Migraine

When to use vs. 8A82: Use 8A80 when the headache has typical duration of 4-72 hours, is frequently bilateral or alternating unilateral, accompanied by nausea and/or photophobia/phonophobia, and autonomic symptoms, if present, are not prominent. Migraines may have visual or sensory aura preceding the pain.

Main difference: Migraine has longer duration, autonomic symptoms are not prominent or consistent, and the patient typically seeks rest in a dark and quiet environment, in contrast to the characteristic restlessness of trigeminal autonomic cephalalgias. The presence of nausea is common in migraine but not in trigeminal autonomic cephalalgias.

8A81: Tension-Type Headache

When to use vs. 8A82: Use 8A81 when the headache is bilateral, with pressing or tightening quality (not pulsatile), mild to moderate intensity, without significant autonomic symptoms, and not aggravated by routine physical activity. Absence of nausea and vomiting (mild photophobia or phonophobia may be present, but not both).

Main difference: Tension-type headache is typically bilateral, mild to moderate intensity, without prominent autonomic symptoms. It does not present the pattern of discrete attacks with ipsilateral autonomic symptoms characteristic of 8A82. The quality of pain (pressing vs. lancinating/burning) also differs significantly.

8A83: Other Primary Headache Disorder

When to use vs. 8A82: Use 8A83 only for primary headaches that do not fit into the well-defined categories of migraine, tension-type headache, or trigeminal autonomic cephalalgias. This is essentially a residual code.

Main difference: If characteristics of trigeminal autonomic cephalgia are present (strict unilaterality and prominent ipsilateral autonomic symptoms), always use 8A82. Code 8A83 is reserved for atypical presentations that do not meet criteria for the main categories.

Differential Diagnoses

Secondary Headaches: Conditions such as carotid or vertebral artery dissection, aneurysms, tumors of the sellar or parasellar region, and Horner syndrome can mimic aspects of trigeminal autonomic cephalalgias. Investigation with appropriate neuroimaging is essential. Presence of focal neurological signs, sudden "thunderclap" onset, or symptom progression suggests a secondary cause.

Trigeminal Neuralgia: Characterized by paroxysmal facial pain, extremely brief (seconds), with electric shock quality, triggered by mild stimuli in trigger zones. Absence of prominent autonomic symptoms differentiates it from trigeminal autonomic cephalalgias.

Acute Sinusitis: Can cause unilateral facial pain with nasal congestion, but there is usually evidence of infection (fever, purulent discharge), pain does not have the pattern of discrete attacks, and there are no other autonomic symptoms such as profuse tearing or ptosis.

Acute Glaucoma: Can cause intense unilateral orbital pain with tearing and ocular redness, but ophthalmologic examination reveals elevated intraocular pressure, opaque cornea, and fixed mid-dilated pupil, differentiating it from trigeminal autonomic cephalalgias.

8. Differences with ICD-10

Equivalent ICD-10 Code:

In ICD-10, trigeminal autonomic cephalalgias were coded primarily under G44.0 (Cluster headache syndrome) or G44.8 (Other specified headache syndromes), depending on the specific subtype. There was no specific unifying category for all trigeminal autonomic cephalalgias.

Main Changes in ICD-11:

ICD-11 introduces code 8A82 as a specific and comprehensive category for trigeminal autonomic cephalalgias, formally recognizing this group of disorders as a distinct entity with shared pathophysiology. This change reflects advances in understanding the underlying neurobiological mechanisms.

The hierarchical structure in ICD-11 is clearer and more logical, facilitating appropriate coding. The definition explicitly emphasizes the combination of unilateral headache and trigeminal autonomic activation as defining characteristics, providing more specific guidance for coders.

ICD-11 also offers better granularity, allowing more detailed specification of subtypes when necessary, while maintaining the general category 8A82 for use when the specific subtype is not determined or for broader epidemiological purposes.

Practical Impact of Changes:

The introduction of code 8A82 significantly improves the ability to track this group of disorders epidemiologically. Researchers and health managers can now more easily identify patients with trigeminal autonomic cephalalgias in administrative databases.

For clinicians, the more specific category facilitates communication between professionals and institutions, reducing ambiguity in coding. This can positively impact access to specific treatments and procedure approval.

The transition from ICD-10 to ICD-11 requires updating health information systems and training professionals responsible for coding. During the transition period, it may be necessary to maintain mapping between old and new codes for continuity of historical records.

9. Frequently Asked Questions

1. How is the diagnosis of trigeminal autonomic cephalalgias made?

The diagnosis is essentially clinical, based on detailed history and physical examination. There is no specific laboratory or imaging test that confirms the diagnosis. The physician seeks to identify the characteristic pattern of unilateral pain accompanied by prominent ipsilateral autonomic symptoms. Headache diaries are valuable tools for documenting frequency, duration, and characteristics of attacks. Imaging studies, such as brain magnetic resonance imaging, are generally requested to exclude secondary causes, especially in cases of recent onset or atypical features, but not to confirm the diagnosis of primary headache. Direct observation of an attack, when possible, provides valuable objective diagnostic evidence.

2. Is treatment available in public health systems?

The availability of specific treatments varies among different health systems and regions. Acute treatments include high-flow oxygen therapy and specific medications, while preventive treatments involve various classes of drugs. Many public health systems provide access to at least some therapeutic options, although the full range of treatments may not be universally available. Patients should consult with their physicians and local health services about available options. Advocacy with health managers may be necessary in some cases to access more specialized or newer treatments.

3. How long does treatment last?

The duration of treatment varies significantly depending on the pattern of the disorder and individual response. For episodic forms, preventive treatment may be necessary during active periods (which may last weeks to months) and can be discontinued during remissions. Chronic forms may require continuous preventive treatment for prolonged periods, sometimes years. Acute treatments are used as needed during each attack. Management is often long-term, with periodic adjustments based on response and evolution of the condition. Regular medical follow-up is essential for therapeutic optimization and monitoring of adverse effects.

4. Can this code be used in medical certificates?

Yes, code 8A82 can and should be used in medical certificates when appropriate. Adequate documentation of the condition in certificates is important to justify absences from work during periods of intense attacks or for related medical procedures. The intensity and frequency of attacks in trigeminal autonomic cephalalgias can result in significant temporary disability, justifying time off from professional activities. Precise coding is also relevant for long-term or permanent disability evaluation processes in severe refractory cases. Healthcare professionals should clearly document the functional impact of the condition when issuing certificates.

5. Can trigeminal autonomic cephalalgias be cured?

There is no definitive "cure" in the sense of permanent elimination of the condition, but many patients experience prolonged remissions, especially in episodic forms. Available treatments can be highly effective in controlling symptoms, reducing frequency and intensity of attacks, and significantly improving quality of life. Some patients achieve complete control with appropriate preventive treatments. In refractory cases, invasive procedures may provide substantial relief. Treatment response is variable among individuals, and finding the ideal therapeutic regimen may require trials with different approaches. Specialized follow-up at centers with experience in headaches is beneficial for complex cases.

6. Can children have trigeminal autonomic cephalalgias?

Although less common than in adults, children and adolescents can develop trigeminal autonomic cephalalgias. Diagnosis in the pediatric population can be more challenging due to difficulties in communicating about symptoms, especially in young children. Clinical presentation may differ slightly, with potentially shorter attacks and autonomic symptoms sometimes less prominent. Evaluation by a specialist with experience in pediatric headaches is recommended. Therapeutic approach in children requires special considerations regarding dosages, safety, and long-term effects of medications.

7. Can stress or emotional factors trigger attacks?

Although trigeminal autonomic cephalalgias have a neurobiological basis, factors such as stress, alterations in sleep patterns, and alcohol consumption are recognized as possible triggers for attacks in some patients. However, unlike some other conditions, these headaches often occur spontaneously without an identifiable trigger. The regular temporal pattern of many attacks (occurring at specific times) suggests involvement of circadian mechanisms more than psychological factors. Stress management and maintenance of regular sleep routines may be useful components of the overall therapeutic plan, but do not replace specific medical treatments.

8. Is specialist follow-up necessary?

Although general practitioners can manage simple and well-controlled cases, follow-up with a neurologist or headache specialist is often recommended, especially for: initial diagnostic confirmation, cases refractory to initial treatments, situations requiring specialized medications or invasive procedures, and patients with atypical or complicated presentations. Specialists have greater familiarity with the full range of therapeutic options and can adjust treatments more precisely. In health systems with limited resources, shared care models between general practitioners and specialists can be implemented effectively.

---

Conclusion:

Trigeminal autonomic cephalalgias, coded as 8A82 in ICD-11, represent an important group of primary headache disorders with distinctive clinical characteristics. Precise coding is fundamental to ensure appropriate care, facilitate research, and allow adequate epidemiological tracking. Healthcare professionals should be familiar with the defining features—unilateral pain and prominent ipsilateral autonomic symptoms—to apply this code correctly. With adequate diagnosis and appropriate treatment, many patients can achieve significant symptom control and substantial improvement in quality of life.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Trigeminal autonomic cephalalgias
2. 🔬 PubMed Research on Trigeminal autonomic cephalalgias
3. 🌍 WHO Health Topics
4. 📊 Clinical Evidence: Trigeminal autonomic cephalalgias
5. 📋 Ministry of Health - Brazil
6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04